Endothelial cell senescence is associated with disrupted cell-cell junctions and increased monolayer permeability by Vincent J D Krouwer et al.
VASCULAR CELL
Krouwer et al. Vascular Cell 2012, 4:12
http://www.vascularcell.com/content/4/1/12RESEARCH Open AccessEndothelial cell senescence is associated with
disrupted cell-cell junctions and increased
monolayer permeability
Vincent J D Krouwer, Liesbeth H P Hekking, Miriam Langelaar-Makkinje, Elsa Regan-Klapisz and Jan Andries Post*Abstract
Background: Cellular senescence is associated with cellular dysfunction and has been shown to occur in vivo in
age-related cardiovascular diseases such as atherosclerosis. Atherogenesis is accompanied by intimal accumulation
of LDL and increased extravasation of monocytes towards accumulated and oxidized LDL, suggesting an affected
barrier function of vascular endothelial cells. Our objective was to study the effect of cellular senescence on the
barrier function of non-senescent endothelial cells.
Methods: Human umbilical vein endothelial cells were cultured until senescence. Senescent cells were compared
with non-senescent cells and with co-cultures of non-senescent and senescent cells. Adherens junctions and tight
junctions were studied. To assess the barrier function of various monolayers, assays to measure permeability for
Lucifer Yellow (LY) and horseradish peroxidase (PO) were performed.
Results: The barrier function of monolayers comprising of senescent cells was compromised and coincided with a
change in the distribution of junction proteins and a down-regulation of occludin and claudin-5 expression.
Furthermore, a decreased expression of occludin and claudin-5 was observed in co-cultures of non-senescent and
senescent cells, not only between senescent cells but also along the entire periphery of non-senescent cells lining a
senescent cell.
Conclusions: Our findings show that the presence of senescent endothelial cells in a non-senescent monolayer
disrupts tight junction morphology of surrounding young cells and increases the permeability of the monolayer for
LY and PO.
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Cellular senescence -also called replicative senescence-
is defined as an irreversible growth arrest occurring in
cultured cells after many population doublings, even
though nutrients, growth factors and sufficient space are
available for cells to divide. Senescent cells are metabo-
lically active and they undergo profound changes in
morphology and function. Cellular senescence is asso-
ciated with alterations in gene- and protein expression
[1-8]. Growing evidence indicates that cellular senes-
cence also occurs in vivo, although the detection of* Correspondence: j.a.post@uu.nl
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reproduction in any medium, provided the orsenescent cells in tissues is based on markers that are
not exclusive for the senescent state [3,9]. The concept
that cellular senescence contributes to organismal ageing
and to age-related pathologies is well-accepted, but still
rather speculative [9]. This concept is supported by the
increased occurrence of senescent cells with age, and by
the presence of senescent cells specifically at sites of
age-related pathologies, such as atherosclerosis [10,11].
Endothelial cells form the monolayer lining the lu-
minal surface of the entire vascular system. One of their
main functions is to provide a semi-permeable barrier
between the blood and the underlying tissues. Two path-
ways regulate endothelial permeability, namely the trans-
cellular pathway, by which blood components pass
through the cell, and the paracellular pathway, byl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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through intercellular cell-cell junctions. Endothelial
adherens junctions comprise the endothelial-specific
transmembrane protein Vascular Endothelial (VE)-
cadherin, whereas the transmembrane proteins occludin
and endothelial-specific claudin-5 are part of the tight
junctions [12]. The integrity of endothelial cell-cell junc-
tions is crucial for the maintenance of vascular homeo-
stasis, including the maintenance of the endothelial
barrier function. Loss of junctional integrity, leading to
increased vascular permeability, is associated with many
pathological disorders [13]. Endothelial cells, among
many other cell types, can undergo replicative senescence
in vitro. Several genomics and proteomics studies on
endothelial cell senescence reported changes in gene and
protein expression [1,2,7,14]. Some of these changes,
such as decreased eNOS activity and decreased NO pro-
duction [11,15], reduction in mitochondrial membrane
potential [5] and increase of ICAM-1 levels [11,16], di-
rectly correlate with endothelial dysfunction. Although in
general in vivo endothelial turnover is low [17], in
atherosclerotic-prone areas [18,19] -at bifurcations or
other areas of vascular transition- the endothelial cell
turnover is expected to be increased because of chronic
injury due to changes in shear. Senescent endothelial
cells have been identified in vivo [20], specifically at sites
of atherosclerotic lesions [10,11]. Senescent endothelial
cells present at the surface of those lesions express lower
levels of eNOS. It has been proposed that senescence of
endothelial cells contributes to the onset and/or the pro-
gression of atherosclerosis [11,20,21], although a causal
relationship has not been proven.
The accumulation of LDL in the intima of the vessel
wall is one of the initial steps of atherosclerosis [18,19],
this suggests that the endothelium undergoes changes
that compromise its barrier function. Endothelial perme-
ability is affected and regulated by many factors. One of
the key elements in controlling endothelial permeability
is the junctional complex between adjacent endothelial
cells. Little is known about the consequences of the
presence of senescent endothelial cells on the barrier
function of the endothelial monolayer. Recently, a down-
regulation in junction protein expression was reported
upon inhibition of telomerase activity [22] and notch-
induced senescence [23]. In addition, a genomics study
indicated a slight down-regulation of claudin-5 in senes-
cent cells [24]. We hypothesize that the presence of re-
plicative senescent cells in an endothelial monolayer
affects cell-cell interactions and thereby endothelial per-
meability. Therefore, in the present work, we set out to
determine the integrity of adherens and tight junctions
in non-senescent, senescent and in co-cultures of non-
senescent and senescent primary human endothelial
cells. Furthermore, we examined whether the presenceof senescent endothelial cells is associated with increased
endothelial permeability.
We recently showed that cytosolic phospholipase A2α
(cPLA2α) is a critical protein regarding the formation
and maintenance of tight junctions [25]. Because senes-
cence is accompanied by altered gene expression and
cPLA2α plays a key role in tight junction regulation, we
specifically investigated the expression of this protein in
relation to senescence.
Methods
All data presented in this paper were the result of at
least three independent cell isolations and experiments.
Endothelial cell isolations and cultures
Umbilical cords were obtained from the Department of
Obstetrics and Gynecology, Diakonessen Hospital,
Utrecht, The Netherlands, with the informed consent of
the parents. Human umbilical vein endothelial cells
(HUVECs) were isolated and cultured as previous
described [1,26,27]. For non-senescent cells, passages 1
to 4 were used; cells were seeded at a density of 10 000
cells/cm2 and grown for 7 days, after which they formed
a confluent monolayer. Senescent HUVECs were
obtained by repetitive culturing of the cells, as described
in [1]. Senescent cells were used when cells showed the
following senescent characteristics: they seized to proli-
ferate for 3 weeks in complete culture medium and
60%–70% of the cells were positive for SA-β-Gal and
γH2AX. These characteristics showed between passage
21 and 28, depending on the HUVEC isolation. Senes-
cent cell cultures were seeded at a density of 70.000
cells/cm2; a density more than sufficient to form a con-
fluent monolayer, after which they were maintained in
culture for 7 days in order to allow ample time for the
formation of adherens and tight junctions.
For all co-culture experiments, non-senescent cells
were co-cultured with senescent cells of the same isola-
tion in a ratio of 2:1. To be able to use HUVECs of the
same isolation, one part of the HUVECs were directly
frozen after isolation, whereas the other part was cul-
tured until senescence. Prior to the experiments, frozen
HUVECs were thawed and cultured. The co-culture was
allowed to form a confluent layer for 7 days. During
these 7 days only the non-senescent cells divide, altering
the ratio of non-senescent:senescent cells. Frozen and
thawed cells behaved identical to non-frozen cells.
Antibodies
Mouse anti-VE-cadherin clone TEA 1/31 (1:100 dilu-
tion for IF and 1:1000 for WB) was purchased from
Immunotech (Marseille, France; Cat. No. 1597). Rabbit
anti-occludin (1:100 for IF and 1:1000 for WB, Cat.
No. 71-1500) and Mouse anti-claudin-5 (1:200 for IF
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purchased from Zymed Laboratories (South San Francisco,
CA). Mouse anti-cPLA2α (1:100 for WB, Cat. No. sc-454)
and goat anti-cPLA2α (1:30 for IF, Cat. No. sc-1724)
were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA). Alexa Fluor 488-labeled donkey anti-goat,
goat anti-mouse, goat anti-rabbit and Alexa Fluor 555-
labeled goat anti-mouse antibodies were purchased from
Molecular Probes (Eugene, OR) and all used in 1:500 dilu-
tion for IF. Peroxidase-conjugated donkey anti-mouse and
donkey anti-rabbit antibodies were purchased from Jack-
son Immuno Research and used in 1:5000 dilution for WB.
Immunofluorescence microscopy
Processing of HUVEC samples for immunofluorescence
and fluorescent imaging was performed as follows. Cells
were fixed for 15 min at RT in 4% PFA diluted in PBS,
washed 3 × 5 min, incubated in 0.1% Triton X-100
(diluted in PBS) for 10 min at RT, washed 3 × 2 min and
then incubated in 50 mM Glycine in PBS for 10 min at
RT. After washing 3 × 5 min, the 12 mm coverslips were
incubated on 30 ul drops of primary antibody solution
(containing 1% BSA in PBS) for 1 hour at RT. Samples
where then washed 3×10 min, after which secondary anti-
bodies were incubated in the same manner. After antibody
incubation, coverslips where washed for 3× 10 min, incu-
bated for 5 mins in PBS containing 2 ug/ml DAPI, washed
2× 5 min in PBS and 1× quickly in H2O, and mounted on
4 ul drops of ProLong Gold antifade mounting reagent
(Invitrogen, P36930). Samples were allowed to cure at RT
for at least 16 hours before microscopical analysis.
The fluorescence intensity of claudin-5 labeling was
determined at the cell-cell contacts between 1) a non-
senescent and senescent endothelial cell; 2) two non-
senescent cells lining a senescent cell; 3) a non-senescent
cell lining a senescent cell with a non-senescent cell not
directly neighboring a senescent cell and 4) two non-
senescent cells not directly neighboring a non-senescent
cell. Five images were analyzed using ImageJ software
v1.41. In each image, at various locations, 40 lines of
7 μm were drawn perpendicular to the cell-cell contacts.
A plot profile was made of the claudin-5 intensity along
each line and an area of 2.5 μm around the maximal in-
tensity at the cell-cell contacts was analyzed to determine
the fluorescent intensity at the cell-cell contacts. Statistical
analysis was performed using ANOVA followed by
Tukey’s multiple comparison test.
Western blot analysis
Seven day confluent non-senescent and senescent
HUVECs were washed once with HBSS (PAA Laboratories,
Linz, Austria) and incubated on ice for 5 minutes with lysis
buffer (25 mM Tris HCl, pH 8, 1% TX100, 100 mM NaCl,
10 mM EDTA, 1x Complete EDTA-free protease inhibitorcocktail (Roche, 11873580001), and 1 mM Na3VO4). Cells
were scraped and centrifuged for 10 min at 13,000 rpm at
4°C. Supernatants were collected and protein determination
was performed using a BCA protein assay kit (Pierce, Rock-
ford, IL).
Western blot analysis was performed as described pre-
viously [28]. Lysate containing 5 μg of total protein was
loaded on 12% SDS-PAGE for the detection of claudin-
5, and 15 μg total protein on 8% SDS-PAGE for the de-
tection of other proteins. For immuno-detection of
cPLA2α, the mAb (sc-454) was used.
For quantification, regions of interest of a fixed sur-
face area of at least 3 independent experiments were
selected and signal intensities were measured using
ImageJ software v1.41. A region of interest right above
or below the band of interest was used as background
and subtracted from the signal intensity of the band of
interest. Bands of interest were normalized by dividing
the signal intensity of the band of interest by the signal in-
tensity of the corresponding tubulin band, which was used
as a loading control. Signal intensities from different inde-
pendent experiments were then normalized to each other
by expressing the signal fractions of senescent samples as
a percentage of non-senescent cells. Statistical significance
was determined using paired t-tests.
Permeability measurements
HUVECs were cultured for 7 days on 0.4 μm pore size
PET track-etched membrane transwell filters (BD Bios-
ciences cat. No. 353180) coated with a 1:100 dilution of
MatrigelTM (BD Biosciences), see [27] for details. Lucifer
Yellow (LY, 20 μg/ml) and peroxidase (PO, 1.2 μg/ml)
were added to the upper chamber of the transwells.
Samples were taken from the bottom chamber at 1, 2,
3, 4.5, 6 and 24 hours and assayed for fluorescence (LY)
or chemoluminescence (PO) using a BMG Fluostar Op-
tima. Data were normalized to the signal obtained for
the non-senescent monolayer and statistical analysis
was performed using unequal variance ANOVA.Results
HUVECs cultured to passage 28 display characteristics of
senescence
We used senescent cells to examine the potential effects
of endothelial cell senescence on the integrity of endo-
thelial adherens and tight junctions. The major criterion
for cellular senescence was that cells seized to proliferate
for 3 weeks in the presence of complete culture medium.
About 60%–70% of the cells were positive for
senescence-associated β-galactosidase (SA-β-Gal) and
γH2AX (Figure 1a & b). None of the senescent cells
showed incorporation of 5-ethynyl-20-deoxyuridine (EdU,
to monitor DNA replication and thus cell proliferation;
Figure 1 Characteristics of replicative senescent HUVECs.
(a) Senescent-associated β-galactosidase (SA-β-gal) activity staining
of non-senescent and senescent HUVECs (bar 250 μm).
(b) Immunofluorescent labeling of γH2AX with below the
corresponding DAPI images to visualize the nuclei of all HUVECs
(bar 25 μm). (c) Western blot analysis of Cyclin D1 and p21
expression levels in cell lysates of non-senescent and senescent
HUVECs. Cyclin D1 and p21 are typical senescence markers. Tubulin
was used as a loading control.
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strong increase in expression of classical senescent mar-
kers such as p21 and cyclin D1 as determined by West-
ern Blot analysis (Figure 1c).
Adherens and tight junctions are disrupted in replicative
senescent HUVECs
To determine the integrity of junctons in non-senescent
and senescent HUVEC cultures, we examined the sub-
cellular localization of the adherens junction protein
VE-cadherin, and of the tight junction proteins ZO-1,
occludin and claudin-5. Since senescent cells have lost
the capacity to divide, they need to be seeded at high
density to be able to form a confluent monolayer with
established cell-cell contacts. Therefore, senescent cells
were seeded at a higher density than non-senescent cells.
Non-senescent or senescent HUVECs were cultured for
7 days, after which the non-senescent HUVECs had
formed a confluent monolayer displaying well deve-
loped adherens and tight junctions as monitored by
immunofluorescence of endogenous VE-cadherin, ZO-1,
occludin and claudin-5 (Figure 2a, non-senescent cells).
In senescent cells, VE-cadherin was clearly expressed; in-
dicating that the senescent HUVECs indeed establish
cell-cell contacts and retain an essential characteristic of
the endothelial phenotype. However, the distribution pat-
tern of VE-cadherin labeling at the cell-cell contacts was
different and the adherens junctions appeared swollen en
disorganized (Figure 2a, senescent cells). Of the tight
junction proteins, ZO-1 was clearly detectable in senes-
cent cells but the distribution of the labeling was differ-
ent: at cell-cell contacts the distribution was very faint.
Instead, ZO-1 appeared to be located more to the cytosol
compared to non-senescent cells. Western Blot analysis
confirmed normal expression levels of VE-cadherin and
ZO-1 in senescent cells (Figure 2b & c).
In contrast to the relatively small differences in VE-
cadherin and ZO-1 distribution and expression, huge dif-
ferences were observed for tight junction proteins occlu-
din and claudin-5: whereas in non-senescent HUVECs
occludin and claudin-5 were expressed and located at cell-
cell contacts, very little labeling was observed in senescent
cells (Figure 2a). Western-blot analysis indeed showed
strong down-regulation in expression levels of occludin
and claudin-5 in senescent HUVECs (Figure 2b & c).
Adherens and tight junctions are disrupted between
replicative senescent HUVECs and young HUVECs
When endothelial cells become senescent in vivo
[10,11,20], they are most likely in contact with neighbo-
ring non-senescent endothelial cells. To mimic this situ-
ation, we decided to co-culture non-senescent and
senescent HUVECs originating from the same umbilical
cord (Figure 3).
Figure 2 Junctions are disrupted in replicative senescent HUVECs. (a) Immunofluorescent labeling of junction proteins in senescent and
non-senescent HUVECs. The corresponding DAPI staining of senescent HUVECs labeled for occludin and claudin-5 are shown (bar 25 μm).
(b) Western blot analysis of junction protein expression levels in non-senescent and senescent HUVECs. Tubulin was used as a loading control.
(c) Quantitative analysis of Western Blots of three independent experiments as performed in (b).
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junctions were observed in regions with non-senescent
HUVECs (Figure 4a). However, at the cell-cell contacts
between senescent cells and non-senescent cells the la-
beling pattern of VE-cadherin was less regular. In agree-
ment with the distribution of claudin-5 at cell-cell
contacts of senescent cells shown in Figure 2, no expres-
sion of claudin-5 was observed between senescent cells.
Tight junctions are disrupted between young HUVECs
that are in the vicinity of a senescent HUVEC
Intriguingly, non-senescent HUVECs lining a senescent
HUVEC displayed reduced expression of claudin-5 along
its entire periphery, even at cell-cell contacts with neigh-
boring non-senescent cells. This was confirmed byquantification of the labeling intensity of claudin-5 at
the cell-cell contacts between 1) a non-senescent and sen-
escent cell; 2) two non-senescent cells lining a senescent
cell; 3) a non-senescent cell lining a senescent cell with a
non-senescent cell not directly neighboring a senescent
cell and 4) two non-senescent cells not directly next to a
non-senescent cell (Figure 4b). Significant lower fluores-
cence intensity was found at the cell-cell contacts between
a senescent cell and a non-senescent cell compared to the
intensity found between two non-senescent cells.
Co-cultures of young and senescent HUVECs display
increased permeability for PO and LY
The observed alterations in distribution and expression
of junction proteins at cell-cell contacts in non-senescent
Figure 3 Co-culture of young and senescent HUVECs.
(a) Representative photograph of toluidine blue staining of a
co-culture (bar 100 μm). (b) Immunofluorescent labeling of γH2AX.
Only the senescent HUVEC displays positive labeling for γH2AX.
Right image shows the corresponding DAPI staining (bar 25 μm).
Figure 4 Cell-cell contacts between young and senescent
HUVECs are disrupted in co-cultures. (a) Immunofluorescent
labeling of VE-cadherin and claudin-5 in co-cultures of senescent
and non-senescent HUVECs (bar 25 μm). Bottom row shows the
corresponding DAPI labeling. The white arrows in the upper row
indicate lipofuscin autofluorescence; the white stars in the lower row
indicate the nucleus of senescent cells. (b) Fluorescence intensity of
claudin-5 at cell-cell contacts, normalized against the mean intensity
at position 4. Numbers at the x-axis correspond to the positions
indicated in the schematic representation (inset) showing the
senescent cell in white and the non-senescent cells in gray.
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the barrier function of the aged endothelial monolayer.
By using the transwell system we studied over time the
permeability for lucifer yellow (LY; mw= 450 Da) and
horseradish peroxidase (PO; mw= 44000 Da) across the
various types of monolayers. The earliest time-point
was 1 hour after the addition of the tracer molecules;
later samples were taken at 2, 3, 4.5, 6 and 24 hours.
Microscopical analysis of the filters clearly showed that
confluent cell-layers were present at the time of the
permeability assay (Figure 5A).
Already one hour after the start of the assay, 2.5 times
more LY had passed through the senescent monolayer
compared to the non-senescent monolayer (Figure 5B,
Lucifer Yellow). In the co-cultures, the amount of LY
that had passed through the monolayer was 1.5× higher
compared to non-senescent cell cultures.
For the high molecular weight tracer, PO, the senes-
cent cell cultures also displayed highest permeability.
Differences in the passage of PO over the different cul-
tures were most pronounced at the later time-points 6
and 24 hours; 24 hours after the addition of the marker,
PO activity was found to be 18× higher in the lower
compartments of the transwells seeded with senescent
HUVECs compared to the non-senescent HUVECs
(Figure 5b, Peroxidase). In comparison, at the same
time-point the lower compartments of the co-culturesdisplayed a 3.5× higher PO activity compared to non-
senescent HUVECs.
cPLA2α expression is down-regulated upon senescence
In a recent study, we showed that cPLA2α is a key player
in the formation and maintenance of endothelial cell-cell
junctions [25]. Silencing of cPLA2α or inhibition of
cPLA2α activity resulted in an altered distribution of
adherens junctions and reduced presence of tight junc-
tion proteins at the cell-cell contacts of cultured
HUVECs [25]. Since we observe a similar effect on adhe-
rens and tight junctions upon senescence of cultured
HUVECs, we decided to study the expression of cPLA2α
in these cells.
In confluent, non-senescent HUVECs, cPLA2α was
clearly present and located at the Golgi as previously
described [25] (Figure 6a). In senescent HUVECs
Figure 5 Senescence is associated with increased endothelial permeability. (A) Representative light microscopy images of non-senescent,
co-cultured and senescent HUVECs on transwell filters (bar 100 μm). The cells were fixed after the permeability assay was performed and stained
with toluidine blue. (B) Normalized values of transport through cultured non-senescent, co-culture or senescent HUVECs one hour after addition
of LY or 24 hours after addition of PO. The values are normalized against the mean value of the non-senescent cultures. p < 0.01 in all cases.
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observed. Western blot analysis shows that this is at
least partly caused by reduced expression of cPLA2α
(Figure 6b).
Discussion
In this study we provide evidence that replicative senes-
cence causes disrupted cell-cell contacts between endo-
thelial cells (HUVECs). These disrupted cell-cell
contacts are a result of alterations in the distribution of
adherens junction proteins and decreased expression of
tight junction proteins. These alterations are not only
observed between senescent cells, but also at cell-cell
contacts between non-senescent and senescent cells and
along the entire periphery of non-senescent cells lining a
senescent cell. The alterations in distribution and ex-
pression of junction proteins coincides with increased
permeability for small (450 Da) and large (44 kDa) tracer
molecules, indicating that the barrier function is com-
promised. Monolayers of co-cultures of non-senescent
and senescent HUVECs also showed increased perme-
ability for both tracer molecules. In addition, theexpression of cPLA2α, that has been shown to play a
role in the maintenance of the integrity of the endothe-
lial barrier [25], was severely down-regulated in senes-
cent cells. This down-regulation of cPLA2α might play a
role in the decreased barrier function of senescent
monolayers.
Senescent endothelial cells have been identified at sites
of atherosclerotic lesions [10,11] and have been pro-
posed to contribute to the onset and/or the progression
of atherosclerosis [11,20,21]. However, a causal relation-
ship between senescence and the development of athero-
sclerosis has not yet been proven and, to our knowledge,
the effect of replicative senescence on endothelial cell-
cell contacts has not been studied before. Using non-
replicative senescence models (either over-expression or
silencing of specific proteins) did indicate altered barrier
function of an endothelial monolayer [22,23]. Venkatesh et
al. [23] observed that the activation of the notch signaling
pathway in endothelial cells results in a senescence-like
phenotype and is associated with increased permeability of
the monolayer caused by altered VE-cadherin and beta-
catenin expression and localization. Huang et al. [22]
Figure 6 cPLA2α is down-regulated in senescent HUVECs.
(a) Immunofluorescent labeling of cPLA2α in non-senescent and
senescent HUVECs (bar 25 μm). (b) Western blot analysis to detect
cPLA2α in lysates of non-senescent and senescent HUVECs. Tubulin
was used as a loading control.
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of TERT or inhibition of TERT activity, leads to senes-
cent features and affects the junctional complexes, which
is accompanied by reduced expression of tight junction
proteins, including ZO-1. However, no functional mea-
surements were done is this study. In the present study
we did not observe down-regulation of ZO-1, but we
did observe an alteration in distribution of ZO-1.
We have recently shown that Golgi-localized cPLA2α
is involved in Golgi-to-plasma membrane trafficking of
junction proteins [25]. The down-regulation of cPLA2α
in senescent cells, as described in this paper, could
therefore disrupt the trafficking of junction proteins to
the plasma membrane and thereby altering the distribu-
tion and expression of these proteins. Taddei et al. [29]
reported that in endothelial cells clustering of VE-
cadherin at the cell-cell junctions is necessary to induce
transcription of claudin-5. We hypothesize that dis-
rupted trafficking of VE-cadherin to the plasma mem-
brane of senescent cells, at least partly due to the
decreased expression of cPLA2α, causes a decrease in
VE-cadherin signaling in surrounding young cells. Thissubsequently leads to decreased expression of claudin-5
in these young cells.
Senescent cells are known to secrete factors that can
affect the structure and function of neighboring cells
[30]. However, the fact that the effect of senescent cells
on junction morphology is only observed in cells that
are in contact with senescent cells suggests that, in our
setup, secreted factors do not play a role. This is sup-
ported by our finding that pre-conditioned medium
from senescent cells did not effect on the distribution
pattern of claudin-5 and VE-cadherin in non-senescent
cells (data not shown).
We hypothesize that, in vivo, the presence of senescent
endothelial cells exerts the same effect on endothelial
barrier function as in the current in vitro model. Accu-
mulation of low density lipoprotein (LDL) in the intima
can be, at least partially, attributed to disrupted endothe-
lial junctions [31] and is seen as one of the initial steps
in atherogenesis [18,19], especially at bifurcations where
blood flow is disturbed. Since disturbed flow increases
endothelial cell turnover in vivo [32,33], it is to be
expected that endothelial cells at these locations senesce
faster. Indeed, senescent cells have been identified
in vivo in atherosclerotic tissue [10,11]. Once the athero-
sclerotic process starts, the extensive oxidation of LDL
in the intima could lead to mitochondrial damage and
ROS production in endothelial cells [34], further pro-
moting cellular senescence directly or indirectly by an
increased cell death and thus increased cell turnover.
Mathematical modeling of the dynamics of endothelial
cell damage, repair and telomere shortening suggests
that in humans, at an age of 65 years, approximately
2-5% of the vascular endothelial cells are senescent [17].
The presence of senescent endothelial cells might
affect the atherosclerotic process in several ways. First of
all, the compromised junctional complexes and the sub-
sequent increase in vascular permeability due to the
presence of senescent cells in vivo might increase the
transport of LDL over the endothelium, as described
above. Moreover, endothelial cell senescence is accom-
panied by an increase in adhesive properties towards
macrophages [7,16]. This, in combination with the
described decrease in tight junction protein expression
upon senescence, might aid infiltration of the macro-
phages into the vessel wall, especially since claudin-5 is
thought to be one of the most important junction pro-
teins in permeability control [29].
Conclusion
In this study we provide evidence for the detrimental ef-
fect of the presence of senescent endothelial cells in a
non-senescent endothelial monolayer. Replicative senes-
cence affects the adherens junctions and, even more
strongly, tight junctions, and compromises the integrity
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accompanied by a down-regulation of cPLA2α and this
down-regulation might be involved in the described
alterations in cellular junctions. It is tempting to specu-
late that in vivo the presence of senescent endothelial
cells also results in decreased endothelial barrier func-
tion and thereby plays an important role in the initiation
and propagation of atherosclerosis. This clearly needs
further validation.
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